The medication barcode
rule
|
Linear
barcode |
|
2-D
barcode |
Awareness of the value of linear barcodes
in healthcare got a boost with the medication barcode rule, enacted in 2004
in response to the Institute of Medicine’s 1999 To Err is Human report,
which found that as many as 98,000 people die in hospitals each year as a
result of preventable medical errors. The rule mandated that certain human
drug and biological product labels contain a linear barcode consisting of
the National Drug Code (NDC).
Today, Mark Neuenschwander President of The
Neuenschwander Company, estimates 60 percent of hospitals are scanning
medications at the point of care, e.g., the bedside, up considerably from
just a few years ago. But for many, that is still not a high enough
percentage, given that the law went into effect in 2006, but Neuenschwander
says that number represents 70 percent of U.S. hospital beds and that the
laggards are primarily smaller hospitals — not unlike the situation in
retail. Lack of necessary technology to scan barcoded pharmaceuticals,
capture the data and transmit it to clinical, business and financial systems
has been cited as a primary reason why some hospitals and other healthcare
providers are not utilizing the barcodes more extensively.
Unique Device
Identification (UDI) rule
The FDA is expected to issue the final UDI
rule – requiring medical device manufacturers to label their products with
auto ID carriers attached to unique device identifiers or UDIs – later this
year. While hospitals and healthcare systems have been among the strongest
proponents of the UDI rule, some wonder if technology will once again prove
to be a barrier. Unlike the medication barcode rule, the FDA is not
mandating a specific auto ID carrier for UDIs. Instead manufacturers can
choose among a variety of carriers, including linear and 2-D barcodes, as
well as RFID, although the FDA encourages labelers to consider what their
customers can actually capture electronically. For that reason, some
manufacturers have stated they will include both linear and 2-D codes on
labels before eventually switching to the smaller 2-D format that can hold
considerably more data in a smaller space. Scanners that can read 2-D codes
are less common in healthcare and can cost $300-400 each.
Neuenschwander takes exception with those
healthcare providers who argue it is not worth making the investment in auto
ID technology until all healthcare products bear machine readable labels.
Once again, he points to retail, noting that many produce items still carry
a 4-digit code — as opposed to a barcode — that has to be manually entered
at the checkout stand. But few would argue that there is benefit gained — in
terms of accuracy and speed — by being able to scan the majority of items.
The flexibility around auto ID carriers has
some manufacturers and their customers questioning whether 2-D or RFID will
ever replace the linear barcode. Neuenschwander says, absolutely not, noting
that 2-D is still only used on a limited basis in retail. As for RFID, he
says it will probably only augment, but never replace, the barcode. As he
put it, "Just because something is sexy doesn’t mean it’s the best thing to
do." Others in the industry agree, noting that RFID has its place, e.g., for
very expensive medical equipment that moves around a healthcare facility and
must be tracked over a long period of time, while barcodes work just as well
for consumable products.
It’s not the carrier,
it’s the code
Regardless of the format, the real value in
auto ID carriers is the data behind the code. But to work, that data must be
associated with an industry standard code, as opposed to a proprietary
identifier. With proprietary codes, the same number can be used to represent
more than one kind of product. The UDI rule will solve this problem by
requiring the codes to be issued by one of three standards bodies expected
to be named as authorized issuing agencies by the FDA: GS1, HIBCC and ICCBBA.
Because none of these standards bodies use the same codes, there is not the
risk of using the same identifier as there is with proprietary codes.
And it’s how you use it
The real value from auto ID technology
comes when providers and others are able to automate how data is captured
and shared among systems and functions, to understand which products are
being purchased and more importantly used in the delivery of patient care.
But only when there is standardized data and interoperability between
systems can we achieve a more seamless process, with little or no human
intervention. Automation in this manner can reduce both labor and the risk
of data entry errors.
Accurately capturing, sharing and storing
data in a consistent manner across systems also makes it easier for
healthcare providers to track product usage for charge capture, recall
management and comparative effectiveness research, among other activities.
By sharing consumption data with manufacturers, healthcare providers can
also begin to tackle the challenge of lack of demand signals in healthcare.
Better demand signals allow all parties to better manage inventory levels,
another area where the retail industry has achieved significant savings.
Karen Conway is industry
relations director for GHX. She serves on the board of directors of AHRMM,
on the leadership council of the Arizona State University Health Sector
Supply Chain Research Consortium and as co-chair of the HIMSS Supply Chain
Special Interest Group. She is also active in the Strategic Marketplace
Initiative (SMI) and a member of the editorial board of Healthcare
Purchasing News.